The publicly-owned Rosalind Franklin Laboratory, which began processing PCR tests in June 2021, has been mothballed since January 2023.
The UK Health Security Agency said that there is a ‘lack of strong evidence on the effectiveness of NPIs to reduce COVID-19 transmission.’
The publicly-owned Rosalind Franklin Laboratory, which began processing PCR tests in June 2021, has been mothballed since January 2023.
The UK Health Security Agency said that there is a ‘lack of strong evidence on the effectiveness of NPIs to reduce COVID-19 transmission.’